Omega Funds
Omega Funds is a venture capital firm dedicated to investing in the future of medicine. The firm focuses on supporting exceptional founders and entrepreneurs in developing impactful products and platforms across various therapeutic areas, including oncology, immunology, rare diseases, and precision medicine. Omega Funds aims to bring science to patients by investing in innovative solutions that address significant medical needs.
Omega Funds
Portfolio
SoniVie raised $60 million in Round C financing and appointed new board members.
#Medical Devices
NRG Therapeutics announced a £16 million Series A to advance mitochondrial therapeutics for Parkinson’s and ALS.
#Biotechnology
Regeneron is set to acquire Checkmate Pharmaceuticals and its investigational immune activator for potential use in multiple tumor types.
#Biotechnology
Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats.
#Biotechnology
Key People
Managing Director